EXEL (STOCKS)
Exelixis Inc
$42.940000
-0.040000 (-0.09%)
Prev close: $42.980000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Michael M. Morrissey
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $11,512.73M
- Employees
- 1,147
- P/E (TTM)
- 15.47
- P/B (TTM)
- 5.21
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
6
Strong Buy
9
Buy
11
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$0.94 | $0.81 | +0.1324 | +16.39% |
|
Sep 2025 (Q3)
|
$0.69 | $0.63 | +0.0586 | +9.28% |
|
Jun 2025 (Q2)
|
$0.65 | $0.57 | +0.0798 | +14.00% |
|
Mar 2025 (Q1)
|
$0.55 | $0.37 | +0.1809 | +49.01% |
Financial Statements
| Assets | $2.82B |
| Current Assets | $1.40B |
| Accounts Receivable | $309.73M |
| Inventory | $27.40M |
| Other Current Assets | $1.07B |
| Noncurrent Assets | $1.42B |
| Fixed Assets | $104.75M |
| Other Non-current Assets | $1.32B |
| Liabilities | $662.85M |
| Current Liabilities | $373.78M |
| Accounts Payable | $25.35M |
| Other Current Liabilities | $348.43M |
| Noncurrent Liabilities | $289.07M |
| Equity | $2.16B |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $2.16B |
| Liabilities And Equity | $2.82B |